Back
Protagonist Therapeutics Vs. Criteo SA Industry Stock Comparison
Buy
51
PTGX
Protagonist Therapeutics
Last Price:
45.80
Seasonality Move:
18.58%
Sell
2
CRTO
Criteo SA
Last Price:
33.70
Seasonality Move:
3.01%
Buy
51
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $47.62. The Score for PTGX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
2
Criteo SA (CRTO)
is a Sell
Is Criteo SA a Buy, Sell or Hold?
- The current Criteo SA [CRTO] share price is $33.72. The Score for CRTO is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
- CRTO is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $47.62
The current trend is moderately bearish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.96 | Buy |
| Relative Strength Index (14 RSI): | 60.04 | Buy |
| Chaikin Money Flow: | -140534 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.33 - 47.23) | Buy |
| Bollinger Bands (100): | (35.43 - 45.45) | Buy |
CRTO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.76 | Sell |
| Relative Strength Index (14 RSI): | 27.62 | Sell |
| Chaikin Money Flow: | -1514757 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.73 - 42.13) | Sell |
| Bollinger Bands (100): | (38.3 - 45.96) | Sell |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.18 | Buy |
| 20-day SMA: | 45.98 | Buy |
| 50-day SMA: | 44.76 | Buy |
| 200-day SMA: | 34.2 | Buy |
| 8-day EMA: | 47.35 | Buy |
| 20-day EMA: | 46.42 | Buy |
| 50-day EMA: | 44.35 | Buy |
| 200-day EMA: | 35.57 | Buy |
CRTO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.46 | Sell |
| 20-day SMA: | 40.42 | Sell |
| 50-day SMA: | 42.75 | Sell |
| 200-day SMA: | 37.87 | Sell |
| 8-day EMA: | 39.74 | Sell |
| 20-day EMA: | 40.61 | Sell |
| 50-day EMA: | 41.67 | Sell |
| 200-day EMA: | 38.56 | Sell |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.50 per share, and a decrease next year of $2.97 per share.
Criteo SA Earnings Growth & CRTO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.63 per share, and an increase next year of $0.00 per share.
Protagonist Therapeutics Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Criteo SA Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||